Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
• Simeon Bennett via Bloomberg.comA hepatitis C drug combination from Gilead Sciences Inc. (GILD) and Bristol-Myers Squibb Co. (BMY) cured all patients in a trial, demonstrating the success of a cocktail that may never be approved.